Our Board of Directors
Our board is comprised of years of leadership and professional experience; each is committed to our mission to raise awareness and funds in the fight against pediatric cancer.
NCI News Releases
11 December 2018
The latest cancer news from the U.S. government's principal agency for cancer research.-
Ibrutinib plus rituximab superior to standard treatment for some patients with chronic leukemia
A clinical trial showed that ibrutinib plus rituximab is superior to standard treatment for patients age 70 and younger with untreated chronic lymphocytic leukemia (CLL). Findings were announced at the American Society of Hematology annual meeting.
-
Statement from NCI Director Dr. Norman E. Sharpless on the Death of Senator John McCain
Senator John McCain, a long-time supporter of cancer research, passed away on August 25.
-
NCI-led research team develops predictor for immunotherapy response in melanoma
In a new study, NCI-led researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors, a type of immunotherapy.
NCI Fact Sheets
11 December 2018
The latest NCI fact sheets on a wide array of cancer topics including risk factors, prevention, support, treatment, and more.-
Secondhand Smoke and Cancer
A fact sheet that summarizes the studies on the health effects of exposure to environmental (secondhand) tobacco smoke.
-
Primary Bone Cancer
A fact sheet about the diagnosis and treatment of cancers that develop in the bones.
-
Alcohol and Cancer Risk
A fact sheet that summarizes the evidence linking alcohol consumption to the risk of various cancers. Includes information about factors that affect the risk of alcohol-associated cancers, such as a person’s genes and tobacco use.
